Acadian Asset Management
ETON icon

Acadian Asset Management’s Eton Pharmaceutcials ETON Stock Holding History

Acadian Asset Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$541K Buy
+15,013
New +$440K ﹤0.01% 1425
2025
Q4 		– Sell
-26,410
Closed -$573K – 2007
2025
Q3 		$573K Sell
26,410
-366,305
-93% -$6.08M ﹤0.01% 1185
2025
Q2 		$5.59M Sell
392,715
-9,713
-2% -$154K 0.01% 563
2025
Q1 		$5.22M Buy
402,428
+153,923
+62% +$2.33M 0.01% 490
2024
Q4 		$3.31M Buy
248,505
+142,551
+135% +$1.45M 0.01% 637
2024
Q3 		$634K Sell
105,954
-14,620
-12% -$61.8K ﹤0.01% 1027
2024
Q2 		$395K Sell
120,574
-35,812
-23% -$125K ﹤0.01% 1276
2024
Q1 		$585K Buy
156,386
+18,898
+14% +$82.5K ﹤0.01% 969
2023
Q4 		$601K Buy
137,488
+40,224
+41% +$161K ﹤0.01% 988
2023
Q3 		$403K Buy
+97,264
New +$375K ﹤0.01% 1059

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Acadian Asset Management's ETON Position: Q2 2026 in Review

Acadian Asset Management opened a new position in Eton Pharmaceutcials (ETON) in Q2 2026: 15,013 shares worth $541K. The stake represents ﹤0.01% of the portfolio and ranks #1425 among its holdings. This is a return to the name: Acadian Asset Management previously reported a position in ETON as recently as Q3 2025.

Acadian Asset Management first reported a position in ETON in Q3 2023 and has held it in 10 quarters since. The position peaked at $5.59M in Q2 2025. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Acadian Asset Management held 15,013 shares of Eton Pharmaceutcials worth $541K as of Q2 2026.
  • Eton Pharmaceutcials was a new Acadian Asset Management position in Q2 2026.
  • Eton Pharmaceutcials made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1425 holding.
  • Acadian Asset Management first reported a position in Eton Pharmaceutcials in Q3 2023 and has held it in 10 quarters since.
  • Acadian Asset Management's Eton Pharmaceutcials position peaked at $5.59M in Q2 2025.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.